You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Takeda Opens German Plant for Dengue Vaccine Production

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 647 Words

GALWAY, IRELAND--November 18, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Takeda Pharmaceutical (Osaka, Japan) has officially opened its new manufacturing plant in Singen, Germany, for its planned dengue vaccine, TAK-003, which is still in Phase 3 trials.

Within this article: Details opening of new plant, planned dengue vaccine, investment, schedule, related Takeda business and assets sales

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00